Drew Adams

Drew Adams began their career in 2015 as an Associate Professor at Case Western Reserve University, followed by a promotion to Thomas F. Peterson, Jr. Professor of Novel Therapeutics. In 2017, they took on a new role as Convelo/Genentech Project Team Co-Lead at Convelo Therapeutics, Inc., followed by promotions to VP of Discovery and Co-Founder.

Drew Adams completed their Bachelor of Arts degree with Highest Honors in Biochemistry from Swarthmore College in 2003. Drew then went on to pursue their PhD in Chemistry at Harvard University, which they obtained in 2009. Afterward, they worked as a Postdoctoral Researcher in Chemical Biology at the Broad Institute of Harvard and MIT until 2015.